We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$119M
AUM Growth
+$3.11M
Cap. Flow
+$619K
Cap. Flow %
0.52%
Top 10 Hldgs %
22.99%
Holding
184
New
25
Increased
49
Reduced
67
Closed
21

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$881K
2
DRI icon
Darden Restaurants
DRI
+$766K
3
URI icon
United Rentals
URI
+$730K
4
IBP icon
Installed Building Products
IBP
+$692K
5
ACM icon
Aecom
ACM
+$691K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$1.48M
2
ADI icon
Analog Devices
ADI
+$1.13M
3
PRXL
Parexel International Corp
PRXL
+$1.1M
4
MSFT icon
Microsoft
MSFT
+$969K
5
JWN
Nordstrom
JWN
+$833K

Sector Composition

Rank Sector Weight
1 Industrials 18.45%
2 Healthcare 16.9%
3 Consumer Staples 13.84%
4 Financials 13.02%
5 Consumer Discretionary 11.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
26
Amgen
AMGN
$222B
$1.21M 1.02%
7,265
-2,075
-22% -$351K
PB icon
27
Prosperity Bancshares
PB
$8.86B
$1.21M 1.01%
21,975
-950
-4% -$50.4K
TNL icon
28
Travel + Leisure Co
TNL
$4.7B
$1.16M 0.97%
38,209
+1,274
+3% +$40.7K
IBM icon
29
IBM
IBM
$224B
$1.15M 0.96%
7,557
+1,778
+31% +$270K
HW
30
DELISTED
Headwaters Inc
HW
$1.13M 0.94%
66,537
+33,006
+98% +$609K
BMY icon
31
Bristol-Myers Squibb
BMY
$132B
$1.13M 0.94%
20,867
+13,717
+192% +$881K
EMR icon
32
Emerson Electric
EMR
$88.3B
$1.11M 0.93%
20,420
-650
-3% -$34.8K
MET icon
33
MetLife
MET
$62.4B
$1.09M 0.91%
27,489
+13,801
+101% +$519K
T icon
34
AT&T
T
$163B
$1.08M 0.91%
35,266
+1,059
+3% +$33.5K
INDB icon
35
Independent Bank
INDB
$3.99B
$1.07M 0.9%
19,853
-4,175
-17% -$213K
BAC.PRE icon
36
Bank of America Depository Shares Series E
BAC.PRE
$1.48B
$1.05M 0.88%
42,750
+20,300
+90% +$492K
ABT icon
37
Abbott
ABT
$187B
$1.01M 0.85%
23,877
-7,150
-23% -$306K
FDX icon
38
FedEx
FDX
$75.4B
$996K 0.83%
5,700
-2,860
-33% -$468K
MCD icon
39
McDonald's
MCD
$195B
$965K 0.81%
8,367
+4,850
+138% +$575K
HON icon
40
Honeywell
HON
$78B
$917K 0.77%
8,750
+5,927
+210% +$619K
ROL icon
41
Rollins
ROL
$18.2B
$902K 0.76%
69,300
+42,075
+155% +$536K
BRK.B icon
42
Berkshire Hathaway Class B
BRK.B
$1.13T
$892K 0.75%
6,173
– –
SLB icon
43
SLB Ltd
SLB
$75B
$889K 0.75%
11,302
+1,750
+18% +$139K
MRK icon
44
Merck
MRK
$318B
$869K 0.73%
14,590
-25,364
-63% -$1.48M
MSFT icon
45
Microsoft
MSFT
$3.71T
$858K 0.72%
14,902
-17,175
-54% -$969K
AVT icon
46
Avnet
AVT
$7.92B
$829K 0.69%
20,200
+3,400
+20% +$139K
MS icon
47
Morgan Stanley
MS
$340B
$808K 0.68%
25,214
-950
-4% -$28.3K
JWN
48
DELISTED
Nordstrom
JWN
$800K 0.67%
15,425
-17,725
-53% -$833K
HUBB icon
49
Hubbell
HUBB
$27.2B
$773K 0.65%
7,175
+5,125
+250% +$544K
NVS icon
50
Novartis
NVS
$297B
$766K 0.64%
10,830
+642
+6% +$46.8K
1
2
3 4 5

Similar funds

GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TC
Towle & Co Denver, Colorado $257M AUM 73.13% 1-Year Est. Return
FAFN
First Affirmative Financial Network Colorado Springs, Colorado $258M AUM
CIA
Corigliano Investment Advisers Raleigh, North Carolina $256M AUM 54.89% 1-Year Est. Return

New England Research & Management's Q3 2016 Portfolio in Review

As of Q3 2016, New England Research & Management held 184 positions worth $119M, up 2.7% from $116M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

New England Research & Management's Q3 2016 filing shows 25 new, 49 increased, 67 reduced and 21 closed positions. Its largest new stake was Installed Building Products: 19,900 shares worth $714K. The largest sale was Merck, an estimated $1.48M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Staples.

  • New England Research & Management's largest Q3 2016 buy was Installed Building Products: 19,900 shares worth $714K.
  • New England Research & Management added most to Bristol-Myers Squibb in Q3 2016, an estimated $881K increase.
  • New England Research & Management's biggest Q3 2016 reduction was Merck, cutting an estimated $1.48M.
  • New England Research & Management fully exited Analog Devices in Q3 2016, selling an estimated $1.13M.
  • New England Research & Management's ten largest holdings make up 23% of its $119M portfolio in Q3 2016.
  • New England Research & Management opened 25 new positions and closed 21 in Q3 2016.
  • New England Research & Management's portfolio value rose 2.7% quarter-over-quarter to $119M.

Based on New England Research & Management's 13F filing for Q3 2016, filed 5 Oct 2016.